Lansforsakringar Fondforvaltning AB publ Purchases 7,986 Shares of Colgate-Palmolive Company $CL

Lansforsakringar Fondforvaltning AB publ lifted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 3.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 246,586 shares of the company’s stock after buying an additional 7,986 shares during the period. Lansforsakringar Fondforvaltning AB publ’s holdings in Colgate-Palmolive were worth $19,712,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the last quarter. Woodline Partners LP lifted its position in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. boosted its stake in shares of Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the last quarter. Forum Financial Management LP grew its holdings in shares of Colgate-Palmolive by 4.4% in the 2nd quarter. Forum Financial Management LP now owns 5,055 shares of the company’s stock valued at $460,000 after acquiring an additional 211 shares in the last quarter. Finally, AlTi Global Inc. increased its position in shares of Colgate-Palmolive by 27.8% in the second quarter. AlTi Global Inc. now owns 3,038 shares of the company’s stock valued at $276,000 after acquiring an additional 661 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on CL. Evercore increased their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, February 2nd. Barclays raised their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 3rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 13th. Finally, Piper Sandler upped their target price on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Insider Transactions at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. This trade represents a 77.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 184,683 shares of company stock worth $17,486,693 over the last quarter. 0.41% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Performance

NYSE CL opened at $95.07 on Monday. The stock has a market cap of $76.63 billion, a PE ratio of 36.29, a P/E/G ratio of 4.29 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The firm has a 50-day moving average of $85.61 and a 200-day moving average of $82.25. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the prior year, the firm earned $0.91 EPS. The business’s revenue was up 5.8% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s payout ratio is 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.